cyproterone acetate has been researched along with Hormone-Dependent Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastide, C; Bruyère, F; Guy, L; Karsenty, G; Rozet, F | 1 |
| Bosland, MC; Johnson, WD; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Hara, S; Hyochi, N; Isaacs, JT; Ishioka, J; Kageyama, Y; Kihara, K; Singh, P; Urushibara, M | 1 |
| Arriola, E; Dowsett, M; Hui, E; Smith, IE | 1 |
| Akakura, K; Bruchovsky, N; Gleave, ME; Goldenberg, SL; Sullivan, LD | 1 |
| Akakura, K; Bruchovsky, N; Buckley, AR; Goldenberg, SL; Rennie, PS; Sullivan, LD | 1 |
| Michna, H; Schneider, MR; Vollmer, G | 1 |
| Goldenberg, SL; Klotz, LH; Rabbani, F | 1 |
| Denis, L | 1 |
| Bosland, MC; Kelloff, GJ; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Alitalo, K; Härkönen, PL; Joukov, V; Karkkainen, MJ; Ruohola, JK; Valve, EM | 1 |
| Kleemann, D | 1 |
| Fukuoka, M; Kitawaki, J; Okada, H; Yamamoto, T | 1 |
| Forbes, A; Iqbal, MJ; Johnson, PJ; Wilkinson, ML; Williams, R | 1 |
| Abel, P; Cox, J; Farah, N; Fleming, J; Hewitt, G; O'Donoghue, EP; Sandow, J; Sikora, K; Waxman, J; Williams, G | 1 |
| Matsumoto, K; Nakamura, N; Nishizawa, Y; Noguchi, S; Sato, B; Uchida, N | 1 |
| Bollack, C; Rougeron, G | 1 |
1 review(s) available for cyproterone acetate and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
[Hormonal treatment in prostate cancer].
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents, Hormonal; Benzamides; Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Estrogens, Non-Steroidal; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Oligopeptides; Phenylthiohydantoin; Prostatectomy; Prostatic Neoplasms | 2013 |
4 trial(s) available for cyproterone acetate and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Diethylstilbestrol; Drug Therapy, Combination; Follow-Up Studies; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Time Factors | 1995 |
Predictors of pathological stage before neoadjuvant androgen withdrawal therapy and radical prostatectomy. The Canadian Urologic Oncology Group.
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Chi-Square Distribution; Cyproterone Acetate; Humans; Logistic Models; Male; Multivariate Analysis; Neoplasms, Hormone-Dependent; Prognosis; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 1998 |
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine | 1998 |
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogue.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Flutamide; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Phosphoric Monoester Hydrolases; Prostatic Neoplasms; Random Allocation; Testosterone | 1988 |
12 other study(ies) available for cyproterone acetate and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.
Topics: Adenocarcinoma; Alkylating Agents; alpha-Tocopherol; Androgens; Animals; Antioxidants; Cyproterone Acetate; Disease Models, Animal; Drug Therapy, Combination; Male; Methylnitrosourea; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Rats, Wistar; Selenium Compounds; Selenomethionine; Testosterone; Vitamin E | 2010 |
Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
Topics: Allylestrenol; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Cyproterone Acetate; Flutamide; Humans; Imidazolidines; Male; Models, Molecular; Mutagenesis, Site-Directed; Neoplasms, Hormone-Dependent; Nitriles; Plasmids; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Testosterone; Tosyl Compounds; Transcription, Genetic; Transfection | 2007 |
Aromatase inhibitors and male breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyproterone Acetate; Estradiol; Estrogens; Estrogens, Conjugated (USP); Humans; Letrozole; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Phobic Disorders; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Spinal Neoplasms; Testosterone; Treatment Outcome; Triazoles | 2007 |
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Cyproterone Acetate; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Mammary Neoplasms, Experimental; Mice; Middle Aged; Neoplasm Staging; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 1993 |
Tumorigenesis disrupts hormonal regulation of tenascin expression in regressing Dunning R 3327 H prostate carcinoma.
Topics: Androgen Antagonists; Animals; Cyproterone Acetate; Flutamide; Male; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate; Prostatic Neoplasms; Rats; Tenascin; Tumor Cells, Cultured | 1996 |
Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid.
Topics: Alitretinoin; Animals; Anticarcinogenic Agents; Carcinogens; Cyproterone Acetate; Dose-Response Relationship, Drug; Male; Methylnitrosourea; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone; Tretinoin | 1999 |
Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
Topics: Animals; Breast Neoplasms; Cycloheximide; Cyproterone Acetate; Endothelial Growth Factors; Estradiol; Estrogen Antagonists; Female; Humans; Lymphokines; Mammary Neoplasms, Experimental; Mice; Neoplasms, Hormone-Dependent; Protein Synthesis Inhibitors; RNA, Messenger; RNA, Neoplasm; Steroids; Tamoxifen; Testosterone; Toremifene; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
[On the dependency of larynx carcinoma on steroid sex hormones].
Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Cyproterone Acetate; Female; Humans; Laryngeal Neoplasms; Male; Mice; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Precancerous Conditions; Receptors, Androgen; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 2002 |
[Growth inhibition of MCF-7 human breast cancer cells by aromatase inhibitors].
Topics: Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Cyproterone; Cyproterone Acetate; Female; Humans; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1991 |
Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5 alpha-dihydrotestosterone.
Topics: Adult; Aged; Androgen Antagonists; Antineoplastic Agents; Carcinoma, Hepatocellular; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Female; Gonadal Steroid Hormones; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Hormone-Dependent | 1987 |
Action mechanisms of physiological doses of androgen or pharmacological doses of estrogen in growth stimulation of Shionogi carcinoma 115 in mice.
Topics: Animals; Blood Physiological Phenomena; Cattle; Cell Division; Culture Media; Cyproterone; Cyproterone Acetate; DNA Replication; Estradiol; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Hormone-Dependent; Receptors, Androgen; Receptors, Estrogen; Testosterone; Tumor Cells, Cultured | 1987 |
Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
Topics: Androgen Antagonists; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1988 |